Fynch Biosciences
PrivateLast Round
IPO
Mar 19, 2021
Total Funding Raised
$148.6M
Company Overview
Fynch Biosciences operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series D round in September 2020.
Fynch Biosciences is a biotechnology company that develops and manufactures the eVOLVER framework, an automated, scalable platform for laboratory continuous culture and experimental evolution.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Computing Hardware
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fynch Biosciences Comparables
Compare Fynch Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pioreactor Inc. | 82% | |
| LabMaker GmbH | 78% | |
| Getinge AB | 76% |
For institutional investors. Book with your work email.
Fynch Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Mar 19, 2021 | ||||
| Series D | Sep 17, 2020 | ||||
| Series C | Aug 21, 2019 |
For institutional investors. Book with your work email.
Fynch Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Draper Richards Kaplan Foundation | Series A |
| SymBiosis Capital Management | Series C, Series D |
| OMX Ventures | Series D |
| Susquehanna International Group | Series C, Series D |
| Humboldt Fund | Series D |
| Morgan Noble Healthcare Partners | Series C |
| BDT & MSD Partners | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2021
$128M raised in IPO round.
- Sep 17, 2020
$90M round with participation from BDT & MSD Partners and The Baupost Group.
For institutional investors. Book with your work email.
Fynch Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fynch Biosciences's valuation, stock price, and market status.
Is Fynch Biosciences a public or private company?
Fynch Biosciences is a private company.
What is the current stock price of Fynch Biosciences?
Fynch Biosciences is a private company, so its shares have no public market price. Caplight tracks Fynch Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fynch Biosciences worth (valuation)?
Valuation information for Fynch Biosciences is not publicly available.
Can I buy Fynch Biosciences stock?
Fynch Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fynch Biosciences's last funding round?
Fynch Biosciences's most recent funding round was IPO on March 19, 2021.
Who are the main investors in Fynch Biosciences?
Key investors in Fynch Biosciences include Draper Richards Kaplan Foundation, SymBiosis Capital Management, OMX Ventures, Susquehanna International Group, Humboldt Fund.
Will Fynch Biosciences IPO soon?
No public IPO plans have been announced for Fynch Biosciences.
How can I track Fynch Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Fynch Biosciences's shares on secondary markets.